06877 CLSA PREMIUM
- 0.100
- -0.005-4.76%
CLSA PREMIUM News
HK Stocks Active | CLSA Premium (06877) resumed trading after over a year, and surged more than 77% in early trading.
Trading of clsa premium (06877) has been suspended since April 25th, 2023. After resuming trading this morning, it quickly surged, with a peak increase of 77% in the morning session.
clsa premium (06877.HK) resumed trading this morning.
On July 19th, Greelong News announced that the shares of clsa premium (06877.HK) will resume trading at 9:00 am today (19/7/2024).
CLSA Premium's Comeback With Soaring Healthcare Profits
clsa premium (06877.HK) has achieved resumption guidance and plans to resume trading on July 19.
CLSA Premium (06877.HK) announced on July 18th that the board of directors is pleased to announce that all resumption guidance has been reached as of the date of the announcement. The company has applied to the Hong Kong Stock Exchange to resume trading of its shares, effective from 9:00 a.m. on July 19, 2024.
Express News | CLSA Premium - Made an Application to Stock Exchange for Resumption of Trading in Co's Shares From 19 July
Express News | CLSA Premium - Fulfilment of Resumption Guidance and Resumption of Trading
Glory Announcement Selection (HK stocks) | Metallurgical Corporation of China (01618.HK): The amount of new signed contracts in the first half of the year was 67.779 billion yuan, a year-on-year increase of 92.5% in new overseas contracts.
Today's focus: Metallurgical Corporation of China (01618.HK): new contract amount of 677.79 billion yuan in the first half of the year, a year-on-year increase of 92.5% in new overseas contract amount. Metallurgical Corporation of China (01618.HK) announced that the company's new contract amount for January-June 2024 was RMB 677.79 billion, a decrease of 6.2% compared to the same period last year. Among them, the new overseas contract amount was RMB 43.54 billion, a year-on-year increase of 92.5%. Major events: Capital realm (00204.HK) recently signed a strategic cooperation intention agreement with Xinghua Economic Development. Southgobi (01878.HK) and
CLSA Premium Shareholder Plans Major Stake Sale
CLSA PREMIUM (06877) controlling shareholder Citic Securities International intends to transfer 28% to 40% equity of the company according to the agreement.
CLSA PREMIUM (06877) announced that on July 12, 2024, it received a notice from its controlling shareholder, CITIC Securities International, who plans to transfer its holdings of approximately 0.569 billion to 0.813 billion ordinary shares of the company through public solicitation agreements, representing 28% to 40% of the company's issued share capital.
Express News | CLSA Premium Ltd - Transfer in Range of 28% to 40% of Co's Total Issued Share Capital
Express News | CLSA Premium - Notified by Controlling Shareholder of Intention to Transfer Portion of Shares in Co Through Public Solicitation Process
CLSA PREMIUM (06877) profit before tax for the first quarter was approximately HK$1.8 million, up more than 150% year over year
According to the Zhitong Finance App, CLSA PREMIUM (06877) issued an announcement. According to the Group's unaudited comprehensive management accounts for the 3 months ended March 31, 2024, unaudited revenue exceeded HK$20 million, mainly from product sales through the company's B2B and B2C distribution channels. For the three months ended March 31, 2024, unaudited profit before tax was approximately HK$1.8 million, an increase of more than 150% compared with the unaudited profit before tax of HK$700,000 for the three months ended March 31, 2023. Furthermore, compared to the first quarter of 2023
CLSA PREMIUM: 2023 ANNUAL REPORT
CLSA PREMIUM announces annual results, annual profit of HK$9.842 million, and turns year-on-year loss into profit
CLSA PREMIUM (06877) announced audited results for the year ended 31 December 2023. Total revenue from continuing operations was approximately HK$200 million, up 410.37% year on year; annual profit from continuing operations of HK$12.83 million, which turned a year-on-year loss into profit; annual profit of HK$9.842 million, while a loss of HK$31.05 million was recorded in the same period in 2022; and profit of HK$0.48 per share. According to reports, the increase in net profit was mainly due to significant growth in the health care business in 2023, and the revenue from sales of health products exceeded 3 times that of 2022.
CLSA PREMIUM (06877) announced annual results, with an annual profit of HK$9.842 million, turning a year-on-year loss into a profit
CLSA PREMIUM (06877) released Audited for the year ended December 31, 2023...
CLSA PREMIUM: AUDITED RESULTSFOR THE YEAR ENDED 31 DECEMBER 2023
Ministry of Finance: The total profit of state-owned enterprises in 2023 was 4633.28 billion yuan, up 7.4% year-on-year
From January to December, the main efficiency indicators of state-owned and state-owned enterprises across the country continued to grow steadily, and the upward trend was further consolidated.
CLSA Premium to Return to Profit
CLSA PREMIUM (06877) is expected to achieve annual net profit of approximately HK$7.7 million, turning a year-on-year loss into profit
According to Zhitong Finance App, CLSA PREMIUM (06877) issued an announcement. The board of directors of the company expects the Group to obtain a consolidated net profit of about HK$7.7 million for the year ended 31 December 2023, and an audited net loss of about HK$31.1 million for the year ended 31 December 2022. The expected net profit is mainly due to a significant increase in the healthcare business in 2023, and the revenue from sales of health products more than tripled the 2022 revenue. Furthermore, trading continues to be suspended.
CLSA PREMIUM: POSITIVE PROFIT ALERTANDQUARTERLY UPDATE ON PROGRESS OF RESUMPTION
Analysis
Price Target
No Data
